PropertyValue
?:abstract
  • The article informs that multi-site, Phase 3 clinical trial evaluating an investigational COVID-19 vaccine known as AZD1222 has begun, and trial will enroll adult volunteers at 80 sites in the U S to evaluate if the candidate vaccine can prevent symptomatic coronavirus disease 2019 It mentions that the positive results from preclinical research led by National Institutes of Health (NIH) scientists supported the rapid development of this vaccine candidate, with early-stage clinical trials
?:creator
?:journal
  • Neonatology_Today
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins
?:type
?:who_covidence_id
  • #825554
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xcxummil>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xcxummil>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all